These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 1895295)
1. Structure-activity relationships of estrogenic ligands: synthesis and evaluation of (17 alpha, 20E)- and (17 alpha, 20Z)-21-halo-19-norpregna-1,3,5(10),20-tetraene-3,17 beta-diols. Napolitano E; Fiaschi R; Hanson RN J Med Chem; 1991 Sep; 34(9):2754-9. PubMed ID: 1895295 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and estrogen receptor binding of (17 alpha, 20E)- and (17 alpha, 20Z)-21-phenylthio- and 21-phenylseleno-19-norpregna-1,3,5(10),20-tetraene-3,17 beta-diols. Napolitano E; Fiaschi R; Herman LW; Hanson RN Steroids; 1996 Jun; 61(6):384-9. PubMed ID: 8776802 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of 11beta-substituted 21-chloro/iodo-(17alpha,20E/Z)-19-norpregna-1,3,5(10),20-te traene-3, 17beta-diols: high-affinity ligands for the estrogen receptor. Hanson RN; Napolitano E; Fiaschi R J Med Chem; 1998 Nov; 41(24):4686-92. PubMed ID: 9822539 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 17alpha-20E-21-(4-substituted phenyl)-19-norpregna-1,3,5(10),20-tetraene-3,17beta-diols as probes for the estrogen receptor alpha hormone binding domain. Hanson RN; Lee CY; Friel CJ; Dilis R; Hughes A; DeSombre ER J Med Chem; 2003 Jul; 46(14):2865-76. PubMed ID: 12825929 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of (17alpha,20Z)-21-(4-substituted-phenyl)-19-norpregna-1,3,5(10),20-tetraene-3,17beta-diols as ligands for the estrogen receptor-alpha hormone binding domain: comparison with 20E-isomers. Hanson RN; Friel CJ; Dilis R; Hughes A; DeSombre ER J Med Chem; 2005 Jun; 48(13):4300-11. PubMed ID: 15974584 [TBL] [Abstract][Full Text] [Related]
6. Stereochemical probes for the estrogen receptor: synthesis and receptor binding of (17 alpha,20E/Z)-21-phenyl-19-norpregna-1,3,5(10), 20-tetraene-3,17 beta-diols. Hanson RN; Herman LW; Fiaschi R; Napolitano E Steroids; 1996 Dec; 61(12):718-22. PubMed ID: 8987141 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, receptor binding, and tissue distribution of 7 alpha- and 11 beta-substituted (17 alpha,20E)- and (17 alpha,20Z)-21-[125I]iodo-19-norpregna-1,3,5(10),20-tetraene-3,17-diols. Ali H; Rousseau J; Ghaffari MA; van Lier JE J Med Chem; 1991 Feb; 34(2):854-60. PubMed ID: 1995909 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of isomeric (17alpha,20E)-11beta-methoxy-21-(trifluoromethylphenyl)-19-norpregna-1,3,5(10),20-tetraene-3,17beta-diols as ERalpha-hormone binding domain ligands: effect of the methoxy group on receptor binding and uterotrophic growth. Hanson RN; Tongcharoensirikul P; Dilis R; Hughes A; Desombre ER J Med Chem; 2007 Feb; 50(3):472-9. PubMed ID: 17266199 [TBL] [Abstract][Full Text] [Related]
10. 3,17 beta-Dihydroxy-20,21-epoxy-19-norpregna-1,3,5(10)-trienes: synthesis, rearrangement, cytotoxicity, and estrogen-receptor binding. Gill JC; Lockey PM; Marples BA; Traynor JR J Med Chem; 1986 Aug; 29(8):1537-40. PubMed ID: 3735321 [TBL] [Abstract][Full Text] [Related]
11. Conformational studies on (17alpha,20Z)-21-(X-Phenyl)-19-norpregna-1, 3,5(10),20-tetraene-3,17beta-diols using 1D and 2D NMR spectroscopy and GIAO calculations of (13)C shieldings. Sebag AB; Friel CJ; Hanson RN; Forsyth DA J Org Chem; 2000 Nov; 65(23):7902-12. PubMed ID: 11073597 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, receptor binding, and tissue distribution of (17 alpha,20E)- and (17 alpha,20Z)-21-[125I]iodo-19-norpregna-1,3,5(10), 20-tetraene-3,17-diol . Ali H; Rousseau J; Ghaffari MA; van Lier JE J Med Chem; 1988 Oct; 31(10):1946-50. PubMed ID: 3172127 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and estrogen receptor binding of novel 11 beta-substituted estra-1,3,5(10)-triene-3,17 beta-diols. Hanson RN; Napolitano E; Fiaschi R J Med Chem; 1990 Dec; 33(12):3155-60. PubMed ID: 2258901 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of (17 alpha,20E)21-[125I]iodo-11-substituted-19-norpregna-1,3,5(10), 20-tetraene-3,17 beta-diols: the influence of 11-stereochemistry on tissue distribution of radioiodinated estrogens. Hanson RN; Franke LA; Kaplan ML Int J Rad Appl Instrum B; 1989; 16(1):3-9. PubMed ID: 2714998 [TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor based imaging agents. 1. Synthesis and receptor binding affinity of some aromatic and D-ring halogenated estrogens. Heiman DF; Senderoff SG; Katzenellenbogen JA; Neeley RJ J Med Chem; 1980 Sep; 23(9):994-1002. PubMed ID: 7411555 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of 17alpha-E-(trifluoromethylphenyl)vinyl estradiols as novel estrogen receptor ligands. Hanson RN; Lee CY; Friel C; Hughes A; DeSombre ER Steroids; 2003 Feb; 68(2):143-8. PubMed ID: 12606005 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of A-ring fluorinated derivatives of (17 alpha,20E/Z)-[125I]iodovinylestradiols: effect on receptor binding and receptor-mediated target tissue uptake. Ali H; Rousseau J; van Lier JE J Med Chem; 1993 Oct; 36(21):3061-72. PubMed ID: 8230092 [TBL] [Abstract][Full Text] [Related]
19. 17 alpha-Z-[125I]iodovinyloestradiol and its 3-acetate: chemical synthesis in vivo distribution studies in the rat. Comparison of tissue accumulation and metabolic stability with 17 alpha-E-[125I]iodovinyl and 16 alpha-[125I]iodo oestradiols. Symes EK; Bishop PB; Coulson WF; Davies AG Biochem Pharmacol; 1992 Aug; 44(4):741-6. PubMed ID: 1510721 [TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor binding characteristics of 1,11 beta-ethanoestradiol: effect of a 1,11 beta-bridge on steroidal estrogen. Napolitano E; Fiaschi R; Hanson RN J Steroid Biochem Mol Biol; 1990 Oct; 37(2):295-300. PubMed ID: 2268562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]